Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial

J Russel; K Heissner; T Behlendorf; A Stein; L Lindner; K Jordan; T Kegel; HJ Schmoll

Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial

J Russel
, K Heissner
, T Behlendorf
, A Stein
, L Lindner
, K Jordan
, T Kegel
, HJ Schmoll

Universitätsklinik für Innere Medizin 3 - Pneumologie, Allergologie, Schlafmedizin

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	150-151
Fachzeitschrift	ONKOLOGIE
Jahrgang	35
Publikationsstatus	Veröffentlicht - 2012

Dieses zitieren

Russel, J., Heissner, K., Behlendorf, T., Stein, A., Lindner, L., Jordan, K., Kegel, T., & Schmoll, HJ. (2012). Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial. ONKOLOGIE , 35, 150-151.

Russel, J ; Heissner, K ; Behlendorf, T et al. / Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial. in: ONKOLOGIE 2012 ; Jahrgang 35. S. 150-151.

@article{e196b3aae23c4737917701524635d6ae,

title = "Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial",

author = "J Russel and K Heissner and T Behlendorf and A Stein and L Lindner and K Jordan and T Kegel and HJ Schmoll",

year = "2012",

language = "English",

volume = "35",

pages = "150--151",

journal = "ONKOLOGIE ",

issn = "0378-584X",

}

Russel, J, Heissner, K, Behlendorf, T, Stein, A, Lindner, L, Jordan, K, Kegel, T & Schmoll, HJ 2012, 'Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial', ONKOLOGIE , Jg. 35, S. 150-151.

Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial. / Russel, J; Heissner, K; Behlendorf, T et al.
in: ONKOLOGIE , Jahrgang 35, 2012, S. 150-151.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial

AU - Russel, J

AU - Heissner, K

AU - Behlendorf, T

AU - Stein, A

AU - Lindner, L

AU - Jordan, K

AU - Kegel, T

AU - Schmoll, HJ

PY - 2012

Y1 - 2012

M3 - Abstract (Journal)

SN - 0378-584X

VL - 35

SP - 150

EP - 151

JO - ONKOLOGIE

JF - ONKOLOGIE

ER -

Russel J, Heissner K, Behlendorf T, Stein A, Lindner L, Jordan K et al. Phase II randomized clinical trial of Pazopanib alone and Pazopanib plus Gemcitabine in relapsed or metastatic soft tissue sarcoma. The PAPAGEMO trial. ONKOLOGIE . 2012;35:150-151.